About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Treatment for Fatty Liver Disease Uncovered

by Colleen Fleiss on May 26, 2019 at 3:30 PM
Font : A-A+

New Treatment for Fatty Liver Disease Uncovered

In patients suffering from an untreatable type of fatty liver disease called non-alcoholic steatohepatitis (NASH) deactivating a specific protein interleukin 11 (IL11) - with drugs called therapeutic antibodies, reverses inflammation and scarring of the liver, revealed a team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore (NHCS). The findings,1 published in the top journal for liver and gut diseases, Gastroenterology, have implications for the development of drugs to treat the disease.

Fatty liver disease is very common in Singapore and affects approximately one in four people around the world. People with diabetes and obesity are particularly at risk. Fatty liver disease can progress to cause liver inflammation, fibrosis and NASH, which increases the risk of liver failure. There is currently no treatment for fatty liver disease and NASH, and drugs tested in patients thus far have failed to work.

Advertisement


"We questioned whether the IL11 protein is important for fat accumulation, scarring and inflammation of the liver due to the overconsumption of fatty food and sugary drinks. Our team found that this protein is very important for these processes, and inhibiting it can not only prevent fatty liver disease but also reverse it after it has taken hold of the liver," said Dr Anissa Widjaja, Senior Research Fellow at Duke-NUS' Cardiovascular and Metabolic Disorders (CVMD) Programme and first author of this study.

The team found that the IL11 gene triggers the development of NASH and fat accumulates in the livers of people with the condition. It is most common in people who are obese and diabetic, and causes fatigue, abdominal pain, itchy skin, nausea, and can ultimately lead to liver cirrhosis or cancer.
Advertisement

"Millions of people are affected by diabetes and dangerous fatty liver disease - we have identified a new approach to treat these patients and restore their liver function, while lowering the dangerous fats and glucose in their blood," added Professor Stuart Cook, corresponding author of the study, who is the Tanoto Foundation Professor of Cardiovascular Medicine and Director of the CVMD Programme at Duke-NUS, Senior Consultant at NHCS, and Director and Co-Founder of Enleofen Bio, a biotechnology company established in Singapore that is now developing the antibody therapeutics for clinical trials. The company aims to have the drugs ready for clinical trials by the end of 2020.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Insulin Resistance Doubles the Risk of Major Depressive Disorder
Emotional Healing
Psychosis Risk Related to Cat Parasite
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Alcoholic Liver Disease Liver Biopsy Hepatitis A Liver Wilson's Disease Biliary Cirrhosis Milk Thistle Current Treatments for Liver Cancer Fatty Liver Disease: A Growing Health Problem in India Living Donor Liver Transplant: What Are the Risks? 

Recommended Reading
Fatty Liver Disease: A Growing Health Problem in India
Non alcoholic fatty liver disease (NAFLD) is the leading cause of liver dysfunction worldwide and .....
High Rates of Liver Disease Progression Seen in Non-alcoholic Fatty Liver Disease Patients
Within 10 years of diagnosis, up to 11% of patients with NAFLD/NASH had progressed to advanced ......
Quiz on Liver
How many of us know that the liver is a vital organ the size of an American Football? To understand ...
Alcoholic Liver Disease
Encyclopedia section of medindia gives general information about Alcoholic Liver ......
Biliary Cirrhosis
Biliary cirrhosis occurs due to obstruction to the flow of bile through bile ducts either within the...
Current Treatments for Liver Cancer
Current Treatments for Liver Cancer (also known as hepatoma or hepatocellular carcinoma) can result ...
Hepatitis A
Hepatitis A is the most benign of the hepatitis viruses and usually has no long term side effects. H...
Living Donor Liver Transplant: What Are the Risks?
The risk of dying as a result of a living donor liver segment removal is between 0.2-2.0%. The risk ...
Milk Thistle
Milk Thistle is a resourceful natural plant which has many medicinal benefits. In herbal medication ...
Wilson's Disease
This is a rare inherited systemic disorder of copper metabolism, affecting the liver mainly before o...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use